Last updated: February 24, 2026
What is NDC 70677-1116?
NDC 70677-1116 refers to a specific drug identified by the National Drug Code. Based on available data, this code corresponds to "Sildenafil Citrate Tablets, 100mg" marketed primarily for the treatment of erectile dysfunction. Market data sourced from the FDA and commercial claims suggest this is a branded or generic form of sildenafil, with variations in pricing depending on manufacturer, formulation, and distribution channels.
Market Overview
Market Size and Demand
The global erectile dysfunction (ED) market was valued at approximately $4.5 billion in 2021 and is projected to grow at a compound annual growth rate (CAGR) of 7.2% through 2027 [1].
-
U.S. Market Context: The U.S. represents about 40% of the global ED drug market. Approximately 30 million men in the U.S. have ED, with about 20 million actively using prescription medications such as sildenafil [2].
-
Prescription Volume: The number of prescriptions for sildenafil across pharmacies has plateaued at approximately 8 million annually in recent years. Generic sales account for roughly 60% of prescriptions, with branded versions remaining dominant among certain patient segments [3].
Competitive Landscape
Key market players include Pfizer, Teva, Mylan, and Lupin. Pfizer’s Viagra remains a well-known brand, but generics like sildenafil tablets command a significant share.
| Manufacturer |
Estimated Market Share |
Key Products |
| Pfizer |
40% |
Viagra |
| Teva |
20% |
Sildenafil citrate (generic) |
| Mylan |
15% |
Sildenafil citrate (generic) |
| Others |
25% |
Various generics |
Regulatory Status
The FDA approved sildenafil citrate tablets as a generic drug in 2017, leading to increased market competition and price declines [4].
Price Analysis
Current Pricing
-
Brand Name (Viagra): Retail prices hover around $70-$80 per tablet for 100mg doses. Insurance coverage reduces out-of-pocket costs but varies.
-
Generic Sildenafil (NDC 70677-1116): Wholesale prices average approximately $1-$2 per tablet. Retail prices range from $4 to $7 per tablet based on pharmacy and location.
| Price Point |
Range (per tablet) |
Notes |
| Wholesale |
$0.50 - $1.50 |
Typical bulk purchasing |
| Retail (cash) |
$4 - $7 |
Without insurance |
| Insurance Co-pay |
$0 - $2 |
Varies by plan |
Price Trends
Since FDA approval of generics, prices have declined approximately 80%. The trend indicates continued price pressure due to increased generic competition.
Price Projections (Next 5 Years)
| Year |
Expected Price Range (per tablet) |
Key Drivers |
| 2023 |
$4 - $7 |
Stable, with minor fluctuations |
| 2024 |
$3.50 - $6 |
Increased generic competition and potential biosimilar entry |
| 2025 |
$3 - $5 |
Price erosion, potential patent challenges on higher-cost brands |
| 2026 |
$2.50 - $4.50 |
Market saturation, direct-to-consumer distribution strategies |
| 2027 |
$2 - $4 |
Potential new formulations or delivery methods influencing pricing |
Influencing Factors
- Patent Expirations: The patent for Viagra expired in 2017; new patents or exclusivities are unlikely to emerge for sildenafil.
- Market Penetration: Greater adoption of OTC or lower-cost generics could further drive prices down.
- Regulatory Changes: Potential health policies promoting price transparency or importation could influence pricing.
- Formulation Innovations: Extended-release or combination therapies may command higher prices but are unlikely to impact standard tablets significantly.
Strategic Considerations for Stakeholders
- Manufacturers: Focus on cost-efficient production, patent challenges, or formulation improvements to differentiate.
- Distributors/Retailers: Leverage bulk procurement and insurance negotiations to improve margins.
- Investors: Watch for shifts toward biosimilars or new delivery methods that could disrupt current pricing models.
Key Takeaways
- NDC 70677-1116 corresponds to generic sildenafil citrate 100mg tablets.
- The market is mature with stable demand, primarily driven by generics.
- Current retail prices average $4-$7 per tablet, with prices declining rapidly since patent expiration.
- Price projections indicate continued decreases to approximately $2-$4 per tablet over the next five years.
- Competition, regulatory shifts, and formulation innovations are primary factors influencing future pricing.
FAQs
1. Is NDC 70677-1116 a branded or generic drug?
It is a generic drug, having entered the market after patent expiration of Pfizer’s Viagra in 2017.
2. What is the main driver of price decline for this drug?
The entry of multiple generics has increased competition and lowered retail prices substantially.
3. Will the price of sildenafil tablets increase again?
Likely not in standard formulations unless new patents or formulations emerge. Price increases could occur with new delivery methods or indications.
4. How does insurance coverage impact the price?
Insurance often reduces out-of-pocket costs, sometimes bringing effective prices below $2 per tablet.
5. What is the future market outlook for sildenafil?
It remains a saturated market with declining prices. Innovations or new formulations might create premium segments, but standard tablets are expected to remain low-cost.
References
[1] Grand View Research. (2022). Erectile Dysfunction Market Size, Share & Trends Analysis.
[2] American Urological Association. (2021). Erectile Dysfunction Statistics.
[3] IQVIA. (2022). Prescription Data for Erectile Dysfunction Medications.
[4] U.S. Food and Drug Administration. (2017). Approval of Generic Sildenafil.
